Life sciences

COVID-19 Molecular Structure and Therapeutics Hub

Aggregating critical information to accelerate drug discovery for the molecular modeling and simulation community. A community-driven data repository and curation service for molecular structures, models, therapeutics, and simulations related to computational research related to therapeutic opportunities for COVID-19 (caused by the SARS-CoV-2 coronavirus).

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

Most data will be in an open license provided by the contributing individual(s). Neither MolSSI nor BioExcel hold the license(s) for data in the data set unless explicitly noted.

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources

Clinical trialsOpen API

ClinicalTrials.gov Study Records

Registered clinical studies, recruitment status, interventions, conditions, sponsors and reported results. Searchable structured records available through the ClinicalTrials.gov API.

ClinicalTrials.gov / U.S. National Library of Medicine

Drug safetyOpen API

FDA Drug Adverse Event Reports

Publicly releasable drug adverse event and medication error reports drawn from FAERS, provided as queryable JSON through openFDA.

U.S. Food and Drug Administration

Population healthPublic download

CDC BRFSS 2025 Survey Microdata

Annual U.S. behavioral risk-factor survey covering chronic conditions, health behaviors and preventive care. The 2025 release contains 356,158 survey records.

Centers for Disease Control and Prevention